Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Shanghai Junshi Biosciences Co., Ltd. has completed a plan reducing the shareholding of major shareholders who held more than 5% of the company’s shares. Before the reduction, Shanghai Tanying and Shanghai Tanzheng together held 8% of the company’s total registered capital. This move might influence the stock’s liquidity and investor perception in the financial markets.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Shareholder Alert for Flux Power Holdings, Inc. (NASDAQ:FLUX)
- ValueAct’s $1B Stake in Meta Platforms is a Constructive Not Activist Bet
- Spirit Airlines Plunges 63% on Possibility of Bankruptcy Deal Wiping Out Shareholders
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
